dc.creatorAguiar C.
dc.creatorBatista A.M.
dc.creatorPavan T.B.S.
dc.creatorAlmeida E.A.
dc.creatorGuariento M.E.
dc.creatorWanderley J.S.
dc.creatorCosta S.C.B.
dc.date2012
dc.date2015-06-26T20:30:36Z
dc.date2015-11-26T14:31:33Z
dc.date2015-06-26T20:30:36Z
dc.date2015-11-26T14:31:33Z
dc.date.accessioned2018-03-28T21:34:55Z
dc.date.available2018-03-28T21:34:55Z
dc.identifier
dc.identifierTropical Medicine And International Health. , v. 17, n. 3, p. 368 - 373, 2012.
dc.identifier13602276
dc.identifier10.1111/j.1365-3156.2011.02936.x
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84857359307&partnerID=40&md5=04e527ed1cdf369b113a59d4096d0a2d
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/97388
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/97388
dc.identifier2-s2.0-84857359307
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1247399
dc.descriptionObjective To evaluate the serological and parasitological status of patients with chronic Chagas disease (CD) after chemotherapy with benzonidazole. Methods Retrospective study of patients treated with benzonidazole (5mg/kg/day for 60days) between 1980 and 2010. Twenty-nine patients who had CD confirmed by two reagent immunological tests and/or one positive xenodiagnosis before treatment were included. Conventional serology (ELISA and IIF) and parasitological tests (haemoculture and N-PCR) were performed. Results At the time of treatment, the mean age of patients was 36±7.24years (20-39years) and the time post-treatment varied from 1 to 29years. After chemotherapy, all individuals had reagent ELISA and 93.1% had positive results for the IIF test. T. cruzi DNA was detected by N-PCR in 48.3%. Negative results were observed in 41.4% and inconclusive ones in 10.3%. Haemoculture was negative for all individuals. Conclusions Our results suggest that N-PCR may be useful in the early identification of therapeutic failure of CD. Although it is difficult to determine parasitological cure in negative N-PCR cases, we can infer that this condition represents a declination of parasitaemia as a favourable consequence of aetiological treatment. © 2011 Blackwell Publishing Ltd.
dc.description17
dc.description3
dc.description368
dc.description373
dc.descriptionBatista, A.M., Aguiar, C., Almeida, E.A., Guariento, M.E., Wanderley, J.S., Costa, S.C.B., Evidence of Chagas disease in seronegative Brazilian patients with megaesophagus (2010) International Journal of Infectious Diseases, 14, pp. 974-977
dc.descriptionBritto, C., Cardoso, A., Silveira, C., Macedo, V., Fernandes, O., Polymerase chain reaction (PCR) as a laboratory tool for the evaluation of the parasitological cure in Chagas disease after specific treatment (1999) Medicina (Buenos Aires), 59, pp. 176-178
dc.descriptionChagas, C., Nova tripanozomiase humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem (1909) Memórias do Instituto Oswaldo Cruz, 1, pp. 159-218
dc.descriptionChiari, E., Dias, J.C.P., Lana, M., Chiari, C.A., Hemocultures for the parasitological diagnosis of human chronic Chagas disease (1989) Revista da Sociedade Brasileira de Medicina Tropical, 22, pp. 19-23
dc.descriptionCoura, J.R., Castro, S.L., A critical review on Chagas disease chemotherapy (2002) Memórias do Instituto Oswaldo Cruz, 97, pp. 3-24
dc.descriptionFabbro, D.L., Streiger, M.L., Arias, E.D., Bizai, M.L., Del Barco, M., Amicone, N.A., Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe City (Argentina), over a mean follow-up of 21years: parasitological, serological and clinical evolution (2007) Revista da Sociedade Brasileira de Medicina Tropical, 40, pp. 1-10
dc.descriptionFernandes, C.D., Tiecher, F.M., Balbinot, M.M., Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up (2009) Memórias do Instituto Oswaldo Cruz, 104, pp. 27-32
dc.descriptionFlores-Chavez, M., Bosseno, M.F., Bastrenta, B., Polymerase chain reaction detection and serologic follow-up after treatment with benznidazole in Bolivian children infected with a natural mixture of Trypanosoma cruzi I and II (2006) American Journal of Tropical Medicine and Hygiene, 75, pp. 497-501
dc.descriptionGallerano, R.R., Sosa, R.R., Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy (2000) Revista de la Facultad de Ciencias Medicas da Universidad Nacional de Córdoba, 57, pp. 135-162
dc.descriptionGomes, M.L., Galvão, L.M.C., Macedo, A.M., Pena, S.D.J., Chiari, E., Chagas disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods (1999) The American Journal of Tropical Medicine and Hygiene, 60, pp. 205-210
dc.descriptionLacunza, C.D., Negrete, O.S., Mora, M.C., Use of the polymerase chain reaction (PCR) for early evaluation of etiological treatment in young adults, chronically infected with Trypanosoma cruzi (2006) Revista da Patologia Tropical, 35, pp. 227-232
dc.descriptionLana, M., Lopes, L.A., Martins, H.R., Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment (2009) Memórias do Instituto Oswaldo Cruz, 104, pp. 1139-1147
dc.descriptionLuz, Z.M.P., Changes in the hemoculture methodology improve the test positivity (1999) Memórias do Instituto Oswaldo Cruz, 94, pp. 295-298
dc.descriptionMarcon, G.E.B., Andrade, P.D., de Albuquerque, D.M., Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies (2002) Diagnostic Microbiology and Infectious Diseases, 43, pp. 39-43
dc.descriptionMarcon, G.E.B., Albuquerque, D.M., Batista, A.M., Trypanosoma cruzi: parasite persistence in tissues in chronic chagasic Brazilian patients (2011) Memórias do Instituto Oswaldo Cruz, 106, pp. 85-91
dc.descriptionMarin-Neto, J.A., Rassi Jr, A., Avezum Jr, A., Mattos, A.C., Rassi, A., The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease (2009) Memórias do Instituto Oswaldo Cruz, 104, pp. 319-324
dc.descriptionConsenso Brasileiro em doença de Chagas (2005) Revista da Sociedade Brasileira de Medicina Tropical, 38 (SUPPL. 3), pp. 1-29. , Ministério da Saúde/Brasil
dc.descriptionMoncayo, A., Ortiz Yanine, M.I., An update on Chagas disease (human American trypanosomiasis) (2006) Annals of Tropical Medicine & Parasitology, 100, pp. 663-677
dc.descriptionMurcia, L., Carrilero, B., Muñoz, M.J., Iborra, M.A., Segovia, M., Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country (2010) Journal of Antimicrobial Chemotherapy, 65, pp. 1759-1764
dc.descriptionEliminação de doenças negligenciadas e outras infecções relacionadas à pobreza (2009) Boletim Epidemiológico, 28. , PAHO/OMS Washington, DC. Available at: (accessed 15 March 2011)
dc.descriptionPortela-Lindoso, A.A.B., Shikanai-Yasuda, M.A., Doença de Chagas crônica: do xenodiagnóstico e hemocultura à reação em cadeia da polimerase (2003) Revista de Saúde Pública, 37, pp. 107-115
dc.descriptionPrata, A., Clinical and epidemiological aspects of Chagas disease (2001) The Lancet Infectious Diseases, 1, pp. 92-100
dc.descriptionSambrook, J., Russel, D.W., (2001) In Molecular Cloning: A Laboratory Manual, p. 2368. , 3rd edn. Cold Spring Harbor, New York
dc.descriptionSolari, A., Ortíz, S., Soto, A., Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3years follow-up by PCR (2001) Journal of Antimicrobial Chemotherapy, 48, pp. 515-519
dc.descriptionUrbina, J.A., Chemotherapy of Chagas' disease: the how and the why (1999) Journal of Molecular Medicine, 77, pp. 332-338
dc.descriptionVago, A.R., Macedo, A.M.M., Adad, S.J., Reis, D.A., Corrêa-Oliveira, R., PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease (1996) The Lancet, 348, pp. 891-892
dc.descriptionViotti, R., Vigliano, C., Armenti, H., Segura, E., Treatment of chronic Chagas disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up (1994) American Heart Journal, 127, pp. 151-162
dc.languageen
dc.publisher
dc.relationTropical Medicine and International Health
dc.rightsfechado
dc.sourceScopus
dc.titleSerological Profiles And Evaluation Of Parasitaemia By Pcr And Blood Culture In Individuals Chronically Infected By Trypanosoma Cruzi Treated With Benzonidazole
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución